尿中的在急性不补偿性心力衰竭中的作用
Mick Hoen1, Delian E Hofman1, Bjorn H A Hompes1
1Department of Cardiology, Zuyderland MC, Heerlen, the Netherlands.
International journal of cardiology. Heart & vasculature
|September 27, 2024
概括
利尿剂耐药性在急性不补偿性心力衰竭 (ADHF) 中很常见. 尿液中低点 (UrNa) 预测结果不佳,并与更严重的心脏脏疾病有关,指导尿剂治疗.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 利尿剂耐药性是急性不补偿性心力衰竭 (ADHF) 的一个重大挑战,导致患者不良后果.
- 斑点尿 (UrNa) 被提出为个性化利尿剂治疗和提高治疗疗效的有价值工具.
- 这项研究调查了利尿剂耐药性的流行,预测低点UrNa的因素及其在未经选择的ADHF人群中的预后影响.
研究的目的:
- 为了前性地评估ADHF患者的利尿剂耐药性患病率.
- 为了确定低点尿 (UrNa) 水平的预测因素.
- 确定点位-UrNa在预测ADHF患者预后结果中的预后价值.
主要方法:
- 招募了143名因ADHF入院并接受静脉注射 (IV) 利尿剂治疗的患者.
- 在IV注射利尿剂后2小时测量了点尿 (UrNa).
- 主要终点是90天内心力衰竭再住院和全因死亡率的复合.
主要成果:
- 低点-UrNa独立地与较差的功能,较低的血清,降低缩血压,先前使用循环利尿剂和SGLT2抑制剂以及较高的利尿剂量有关.
- 绝对点位UrNa水平和尿度≥100 mmol/L都显著预测了复合终点,尽管在混调整后,这已经失去了意义.
- 患有低点UrNa的患者需要更长时间的静脉尿剂治疗和更高的累积剂量.
结论:
- 尿中低点 (UrNa) 在ADHF中普遍存在,特别是在晚期心病患者中.
- 在ADHF中,Spot-UrNa证明了90天心力衰竭无医院生存的显著预后价值.
- 需要进一步的研究来评估UrNa引导的尿剂治疗策略的临床影响.
相关概念视频
01:22Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
01:22Acute Kidney Injury VI: Nursing Management
2
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
2
01:20Acute Kidney Injury V: Interprofessional Care
2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
01:29Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3